Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.

Mayers JR, Torrence ME, Danai LV, Papagiannakopoulos T, Davidson SM, Bauer MR, Lau AN, Ji BW, Dixit PD, Hosios AM, Muir A, Chin CR, Freinkman E, Jacks T, Wolpin BM, Vitkup D, Vander Heiden MG.

Science. 2016 Sep 9;353(6304):1161-5. doi: 10.1126/science.aaf5171.

2.

An old enemy not to be forgotten during PET CT scanning of cancer patients: tuberculosis.

Sümbül AT, Sezer A, Abali H, Gültepe B, Koçer E, Reyhan M, Tonyalı Ö, Özyilkan Ö.

Contemp Oncol (Pozn). 2016;20(2):188-91. doi: 10.5114/wo.2014.43985.

3.

F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors.

Yoshioka M, Uchinami H, Watanabe G, Sato T, Shibata S, Kume M, Ishiyama K, Takahashi S, Hashimoto M, Yamamoto Y.

Springerplus. 2015 Mar 31;4:154. doi: 10.1186/s40064-015-0938-2.

4.

Primed infusion with delayed equilibrium of Gd.DTPA for enhanced imaging of small pulmonary metastases.

Kalber TL, Campbell-Washburn AE, Siow BM, Sage E, Price AN, Ordidge KL, Walker-Samuel S, Janes SM, Lythgoe MF.

PLoS One. 2013;8(1):e54903. doi: 10.1371/journal.pone.0054903.

5.

Properties of noise in positron emission tomography images reconstructed with filtered-backprojection and row-action maximum likelihood algorithm.

Teymurazyan A, Riauka T, Jans HS, Robinson D.

J Digit Imaging. 2013 Jun;26(3):447-56. doi: 10.1007/s10278-012-9511-5.

6.

¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.

Hong R, Lim SC.

World J Gastroenterol. 2012 Jan 14;18(2):168-74. doi: 10.3748/wjg.v18.i2.168.

7.

A systemic review of PET and biology in lung cancer.

Kaira K, Oriuchi N, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N.

Am J Transl Res. 2011 Aug 15;3(4):383-91.

8.

Bronchial stump aspergillosis after lobectomy for lung cancer as an unusual cause of false positive fluorodeoxyglucose positron emission tomography and computed tomography: a case report.

Garcia-Olivé I, Andreo F, Rosiñol O, Sanz-Santos J, Font A, Monsó E.

J Med Case Rep. 2011 Feb 22;5:72. doi: 10.1186/1752-1947-5-72.

9.

Oncologic positron emission tomography: a surgical perspective.

Moore TO, Griffeth LK.

Proc (Bayl Univ Med Cent). 2003 Jan;16(1):13-20. No abstract available.

10.

Current role of positron emission tomography in thoracic oncology.

Lowe VJ, Naunheim KS.

Thorax. 1998 Aug;53(8):703-12. Review.

11.

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.

Thorax. 1997 May;52(5):438-41.

12.

18F-fluorodeoxyglucose PET scans in lung cancer.

Hughes JM.

Thorax. 1996 Aug;51 Suppl 2:S16-22. Review. No abstract available.

13.

PET imaging of primary mediastinal tumours.

Kubota K, Yamada S, Kondo T, Yamada K, Fukuda H, Fujiwara T, Ito M, Ido T.

Br J Cancer. 1996 Apr;73(7):882-6.

Supplemental Content

Support Center